NPPB and Abdominal obesity: Indeed, predictive ability of NT-proBNP for HFpEF remains to be challenged in T2DM patients due to increased proportion of patients having comorbidities (abdominal obesity and chronic kidney disease) that showed bidirectional influence on a clearance of natriuretic peptides [43].